Skip to Content
Merck
CN

P6124

5-(4-Phenoxybutoxy)psoralen

≥98% (HPLC), voltage-gated potassium channel Kv1.3 inhibitor, solid

Synonym(s):

PAP-1

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C21H18O5
CAS Number:
870653-45-5
Molecular Weight:
350.36
UNSPSC Code:
12352200
PubChem Substance ID:
24724583
NACRES:
NA.77
MDL number:
MFCD11114059
Assay:
≥98% (HPLC)
Form:
solid
Quality level:
100
Storage condition:
protect from light

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

5-(4-Phenoxybutoxy)psoralen, ≥98% (HPLC), solid

SMILES string

O=C1Oc2cc3occc3c(OCCCCOc4ccccc4)c2C=C1

InChI

1S/C21H18O5/c22-20-9-8-16-19(26-20)14-18-17(10-13-24-18)21(16)25-12-5-4-11-23-15-6-2-1-3-7-15/h1-3,6-10,13-14H,4-5,11-12H2

InChI key

KINMYBBFQRSVLL-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

solid

storage condition

protect from light

color

white

solubility

DMSO: 9 mg/mL

storage temp.

2-8°C

Quality Level

100

Related Categories

Biochem/physiol Actions

5-(4-Phenoxybutoxy)psoralen (PAP-1) is derived from 5-methoxypsoralen, a natural compound. PAP-1 show higher selectivity for Kv1.3 (voltage-gated potassium channels) than other Kv1 family members. Kv1.3 is predominant on cell membranes of activated effector memory T-cells. Inhibition of Kv1.3 results in membrane depolarization. In rat models, PAP-1 is known to delay the onset of diabetes. It might be used in the treatment of psoriasis and effector memory T cells mediated autoimmune diseases. Oral, intraperitoneal and topical administration of PAP-1 prevents allergic contact dermatitis induced by oxazolone.
Selective inhibitor of Kv1.3, voltage-gated K+ channel.
Selective inhibitor of Kv1.3, voltage-gated K+ channel. PAP-1 (EC50=2 nM) potently inhibits human T effector memory cell proliferation and delayed hypersensitivity. Effective orally or intraperitoneally. 5-(4-Phenoxybutoxy)psoralen has 23-fold selectivity for Kv1.3 over Kv1.5, and 33-125-fold selectivity over other Kv1 family channels.

Features and Benefits

This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

pictograms

Health hazard
GHS08

signalword

Danger

hcodes

H334

Hazard Classifications

Resp. Sens. 1

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000357866
0000357866
0000273675
0000229830
0000229830

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Dai-Chao Ma et al.
Experimental neurology, 332, 113399-113399 (2020-07-12)
After cerebral ischemia/reperfusion injury, pro-inflammatory M1-like and anti-inflammatory M2-like phenotypes of microglia are involved in neuroinflammation, in which NLRP3 inflammasome plays an essential role. Kv1.3 channel has been recognized as neuro-immunomodulatory target, but it is not clear as to its
Joaquim Bobi et al.
Translational research : the journal of laboratory and clinical medicine, 224, 40-54 (2020-06-12)
The modulation of voltage-gated K+ (Kv) channels, involved in cell proliferation, arises as a potential therapeutic approach for the prevention of intimal hyperplasia present in in-stent restenosis (ISR) and allograft vasculopathy (AV). We studied the effect of PAP-1, a selective
Identification of phase-I metabolites and chronic toxicity study of the Kv1. 3 blocker PAP-1 (5-(4-phenoxybutoxy) psoralen) in the rat
Hao B, et al.
Xenobiotica, 41(3), 198-211 (2011)
4-Phenoxybutoxy-substituted heterocycles-A structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1. 3
Bodendiek SB, et al.
European Journal of Medicinal Chemistry, 44(5), 1838-1852 (2009)
Pharmacokinetics, toxicity, and functional studies of the selective Kv1. 3 channel blocker 5-(4-phenoxybutoxy) psoralen in rhesus macaques
Pereira LE, et al.
Exp. Biol. Med, 232(10), 1338-1354 (2007)
View All Related Papers

Articles

Potassium Channels

We offer many products related to potassium channels for your research needs.

钾通道

我们可提供多种与钙通道相关的产品以满足您的各类研究需求。

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service